Apollomics, Inc. (NASDAQ:APLMW) Sees Large Decrease in Short Interest

Apollomics, Inc. (NASDAQ:APLMW) saw a large decrease in short interest in the month of October. As of October 31st, there was short interest totalling 53,800 shares, a decrease of 17.2% from the October 15th total of 65,000 shares. Based on an average trading volume of 22,000 shares, the days-to-cover ratio is presently 2.4 days.

Apollomics Price Performance

NASDAQ:APLMW traded up $0.00 on Friday, reaching $0.01. 317 shares of the company’s stock were exchanged, compared to its average volume of 32,298. The stock has a fifty day simple moving average of $0.01 and a 200-day simple moving average of $0.01. Apollomics has a 52 week low of $0.01 and a 52 week high of $0.06.

Apollomics Company Profile

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.